Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00244608
Status:
COMPLETED
Last Update Posted:
2011-01-24
First Post:
2005-10-25
Brief Title:
A Comparison of the Control of Asthma Provided by Symbicort Turbuhaler Versus Symbicort Turbuhaler Plus Pulmicort Turbuhaler Plus Terbutaline Turbuhaler
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
A Comparison of the Inflammatory Control of Asthma Provided by One Inhalation of Symbicort Turbuhaler 16045 µgInhalation bid Plus As-needed Versus One Inhalation of Symbicort Turbuhaler 3209 µgInhalation bid One Inhalation of Pulmicort Turbuhaler 400 µgDose bid Plus Terbutaline Turbuhaler 04 mgInhalation As-needed A 12-month Randomised Double-blind Parallel-group Active Controlled Multinational Phase IIIB Study in Adult Patients With Asthma EOS
Status:
COMPLETED
Status Verified Date:
2011-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if a flexible dose of Symbicort has a similar effect on the airways of patients with asthma as a higher fixed-dose of Symbicort with additional glucocorticosteroids added
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EudraCT no 2004-004042-41 | None | None | None |